BBVA USA Bancshares’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-6,582
Closed -$225K 530
2016
Q1
$225K Sell
6,582
-7,509
-53% -$297K 0.02% 478
2015
Q4
$1.12M Hold
14,091
0.08% 210
2015
Q3
$827K Buy
14,091
+18
+0.1% +$1.19K 0.06% 238
2015
Q2
$905K Hold
14,073
0.05% 263
2015
Q1
$858K Hold
14,073
0.04% 303
2014
Q4
$824K Hold
14,073
0.04% 318
2014
Q3
$603K Buy
14,073
+1,060
+8% +$47.5K 0.03% 354
2014
Q2
$655K Hold
13,013
0.03% 339
2014
Q1
$574K Hold
13,013
0.03% 348
2013
Q4
$529K Buy
13,013
+6,304
+94% +$233K 0.02% 353
2013
Q3
$226K Buy
+6,709
New +$218K 0.01% 482

Other funds holding ALKS

BBVA USA Bancshares's ALKS Position: Q2 2016 in Review

BBVA USA Bancshares sold out of Alkermes (ALKS) in Q2 2016, closing a stake of 6,582 shares — an estimated $225K sold.

BBVA USA Bancshares first reported a position in ALKS in Q3 2013 and held it in 11 quarters. The position peaked at $1.12M in Q4 2015. 246 funds tracked by Wall St. Rank hold ALKS as of Q2 2016.

  • BBVA USA Bancshares reported no remaining Alkermes position as of Q2 2016 after selling out during the quarter.
  • BBVA USA Bancshares sold 6,582 Alkermes shares in Q2 2016, an estimated $225K.
  • BBVA USA Bancshares first reported a position in Alkermes in Q3 2013 and held it in 11 quarters.
  • BBVA USA Bancshares's Alkermes position peaked at $1.12M in Q4 2015.
  • 246 funds tracked by Wall St. Rank held Alkermes as of Q2 2016.

Based on BBVA USA Bancshares's 13F filing for Q2 2016, filed 29 Jul 2016.